Educational Activities Archives

Medications for opioid use disorder (MOUD) are life-saving, yet three-quarters of people who need them still can’t access them. This episode examines how pharmacy-based models are closing gaps in addiction care deserts, how pharmacists can strengthen interdisciplinary care teams, and why fair reimbursement for pharmacist services matters for sustaining care in the communities hit hardest by overdose.

Substance Use Disorders in Older Adults is a growing problem not only in the United States but throughout the developed world. The Baby Boomer generation, born between 1946 and 1964, is turning 62-80 years old this year. This group is presenting with more Substance Use Disorders and need for substance use treatment now. The use of an artificial cut off age of 65 years as the definition of elderly or old is arbitrary, and this will be discussed. The course will look at the prevalence, screening and treatment of non-medical use of prescription drugs and illicit opioids, as well as use of tobacco, alcohol, stimulants and cocaine, marijuana, and non-opioid sedative hypnotic agents. There are interactive questions throughout the course to help digest and discuss the information presented.

Opioid use disorder (OUD) among women who become pregnant is increasing in prevalence in clinical settings. This course reviews the historical and current context of opioid use of women during pregnancy. The learner will follow the case study of Ashley during her pregnancy and the birth of her baby, and will engage in reflection and knowledge check questions.

Opioids are commonly prescribed for chronic pain, but are also associated with a risk for serious harms, including overdose and opioid use disorder. This course reviews risk factors for opioid misuse, opioid use disorder, and overdose in patients with chronic pain, explains methods for screening and assessing for problematic opioid use, reviews methods for mitigating risks associated with prescribed opioids, and details non-opioid treatment approaches for pain. The course is based on principles in the Center for Disease Control and Prevention’s guideline on opioids for chronic pain and reviews recent evidence on benefits and harms of opioids.

This episode examines how these newer compounds differ pharmacologically, why they are more dangerous, and how clinicians can recognize and respond to kratom-related harms. Listeners will gain practical strategies for identifying kratom use disorder, managing withdrawal, and having informed, non-stigmatizing conversations with patients as these products continue to emerge and change.

Opioid use disorder (OUD) has highly effective FDA-approved medications for its treatment. This course reviews and compares pharmacological treatment options for individuals with OUD, including methadone, buprenorphine (sublingual and injectable formulations), and naltrexone (oral and long-acting intramuscular formulations). Current evidence for each medication is reviewed in detail, and studies comparing each are discussed. The purpose and goal of medications for OUD are reviewed, and different treatment models are presented. The course includes case vignettes in which medication options for OUD are considered.